Christine Erikstrup Hallgreen - Copenhagen Center for Regulatory Science, University of Copenhagen

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 48 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Life Cycle of Vaccines Evaluated by the European Medicines Agency

Debora D. Graf, Lukas Westphal,Christine E. Hallgreen

VACCINEno. 21 (2024)

引用0浏览0WOS引用

Regional Disparity in First-in-Class Anticancer Drug Development in the US, EU, and Japan

Yoshitsugu Hino, Miu Okada,Christine Erikstrup Hallgreen,Marie Louise De Bruin,Randell E. Doty,Naoki Matsumaru,Katsura Tsukamoto

Biological & pharmaceutical bulletin（2023）

引用0浏览0WOS引用

Mapping the information pathways of adverse reactions through clinical event sequences, patient interactions with the healthcare system and generation of different data streams-A qualitative pilot study

Morten Andersen,Christine E. Hallgreen,Andrew Bate

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023): 469-469

引用0浏览0引用

Impact of the 2018 Revised Pregnancy Prevention Programme by the European Medicines Agency on the Use of Oral Retinoids in Females of Childbearing Age in Denmark, Italy, Netherlands, and Spain: an Interrupted Time Series Analysis

Frontiers in Pharmacology（2023）

引用1浏览0WOS引用

Trajectories of EU pediatric investigation plans for oncology approved since 2007 and resulting pediatric cancer indications

Christine E. Hallgreen, Debora D. Graf, Signe H. Andersen

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023): 166-166

引用0浏览0引用

Medication adherence in registration trials supporting the approval of new medicines in the European Union

Katerina M. Mantila,Peter G. M. Mol, Marjon Pasmooij,Christine Erikstrup Hallgreen,Job F. M. van Boven

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY（2022）

引用0浏览0引用

Mandatory Requirements for Pediatric Drug Development in the EU and the US for Novel Drugs—a Comparative Study

Helle Christiansen,Marie L. De Bruin,Christine E. Hallgreen

Frontiers in medicine（2022）

引用0浏览0WOS引用

Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates

Shahab Abtahi,Romin Pajouheshnia, Carlos Duran-Salinas,Judit Riera-Arnau,Magdalena Gamba,Ema Alsina,Christine Erikstrup Hallgreen,Giorgio Limoncella,Claudia Bartolini,Emily Holthuis,Mar Martin-Perez,Jeremy Brown,Miriam Sturkenboom,Olaf Klungel, Other Lot

DRUG SAFETY（2022）

引用0浏览0引用

Impact of EU label changes and revised pregnancy prevention programme for medicinal products containing valproate: utilisation and prescribing trends

Zenodo (CERN European Organization for Nuclear Research) (2022)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn